Pediatrix Medical (MD) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
2.0B
Gross Profit
454.3M
22.57%
Operating Income
183.7M
9.13%
Net Income
-99.1M
-4.92%
EPS (Diluted)
-$1.19
Balance Sheet Metrics
Total Assets
2.2B
Total Liabilities
1.4B
Shareholders Equity
764.9M
Debt to Equity
1.81
Cash Flow Metrics
Operating Cash Flow
-25.5M
Free Cash Flow
184.6M
Revenue & Profitability Trend
Pediatrix Medical Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 2.0B | 2.0B | 2.0B | 1.9B | 1.7B |
| Cost of Goods Sold | 1.6B | 1.6B | 1.5B | 1.4B | 1.3B |
| Gross Profit | 454.3M | 421.6M | 467.0M | 513.2M | 449.3M |
| Operating Expenses | 238.4M | 227.5M | 231.4M | 263.4M | 248.9M |
| Operating Income | 183.7M | 157.9M | 200.0M | 217.7M | 171.9M |
| Pre-tax Income | -101.3M | -48.4M | 81.4M | 135.2M | 7.1M |
| Income Tax | -2.3M | 12.0M | 18.8M | 27.2M | 16.7M |
| Net Income | -99.1M | -60.4M | 66.3M | 130.9M | -796.5M |
| EPS (Diluted) | -$1.19 | -$0.73 | $0.79 | $1.52 | -$9.55 |
Income Statement Trend
Pediatrix Medical Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 639.6M | 483.5M | 428.0M | 840.6M | 1.5B |
| Non-Current Assets | 1.5B | 1.7B | 1.9B | 1.9B | 1.8B |
| Total Assets | 2.2B | 2.2B | 2.3B | 2.7B | 3.3B |
| Liabilities | |||||
| Current Liabilities | 434.1M | 388.9M | 427.0M | 427.4M | 444.3M |
| Non-Current Liabilities | 953.7M | 981.8M | 1.0B | 1.4B | 2.2B |
| Total Liabilities | 1.4B | 1.4B | 1.5B | 1.8B | 2.6B |
| Equity | |||||
| Total Shareholders Equity | 764.9M | 849.1M | 891.6M | 896.7M | 747.7M |
Balance Sheet Composition
Pediatrix Medical Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -99.1M | -60.4M | 62.6M | 108.0M | -9.6M |
| Operating Cash Flow | -25.5M | -10.8M | 108.9M | 65.0M | 223.6M |
| Investing Activities | |||||
| Capital Expenditures | -22.0M | -33.3M | -29.7M | -7.5M | -28.8M |
| Investing Cash Flow | -35.4M | -48.2M | -57.0M | -55.4M | -58.3M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | -14.5M | -25.7M | -487.6M | -760.1M | -530.4M |
| Free Cash Flow | 184.6M | 104.0M | 137.2M | 44.5M | 175.8M |
Cash Flow Trend
Pediatrix Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
7.98
Forward P/E
8.82
Price to Book
1.44
Price to Sales
0.59
PEG Ratio
8.82
Profitability Ratios
Profit Margin
-4.17%
Operating Margin
8.44%
Return on Equity
-10.01%
Return on Assets
5.95%
Financial Health
Current Ratio
1.81
Debt to Equity
83.04
Beta
1.27
Per Share Data
EPS (TTM)
-$1.00
Book Value per Share
$9.38
Revenue per Share
$23.60
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| md | 1.2B | 7.98 | 1.44 | -10.01% | -4.17% | 83.04 |
| HCA Healthcare | 91.0B | 16.80 | -209.92 | 1,605.77% | 8.07% | -106.02 |
| Tenet Healthcare | 15.7B | 10.85 | 3.76 | 28.82% | 7.09% | 152.20 |
| Select Medical | 1.8B | 23.21 | 1.07 | 7.72% | 3.33% | 136.22 |
| National Healthcare | 1.6B | 15.00 | 1.59 | 11.18% | 7.85% | 20.13 |
| Pacs | 2.0B | 21.05 | 3.42 | 110.96% | 2.59% | 469.36 |
Financial data is updated regularly. All figures are in the company's reporting currency.